Four pharma cos to enter European mkt next year
Monday, 18 June 2007
Four leading pharmaceutical companies will qualify to enter with their products in the European markets next year, reports UNB.
"We the four companies will be able to export and fetch US$ 10-15 million each by exporting our products," said Abdul Muktadir, managing director of Incepta Pharmaceuticals Limited Sunday.
He was speaking at a discussion session on 'Pharmaceutical Sector' at the Jatiya Press Club in the city. Bangladesh Aushad Shilpa Samity (BASS) organised the discussion with its president Shafiuzzaman in the chair.
Muktadir did not give further details about the export potentials of pharmaceutical products.
But sources said Incepta, Square, Beximco and Renata pharmaceuticals are ready to export their products. On the other hand, Popular and Healthcare Pharmaceuticals are preparing to export their products in European markets within a short time.
BASS general secretary Nazmul Hassan presented a power-point presentation on "Pharmaceutical Industry in Bangladesh: Some facts and figures".
BASS appealed to the government to re-fix the price of essential drugs for the domestic market, which was fixed in 1982.
In 1982, the government included 150 drugs in the essential list while in 1994, 117 items were identified as common used drugs.
"It is very much irrational to continue with the price that was fixed in 1982," Nazmul said.
He said currently they sell most of the commonly used medicines in the country below the production cost. "It is not possible to continue the production of these essential drugs without raising the price," he said.
Nazmul refuted the report in a section of the press that the manufacturers had increased the price of some essential drugs. "We have no involvement in the price hike," he asserted.
He said there are two types of pricing drugs in Bangladesh - controlled and decontrolled categories. Price of decontrolled drugs is proposed by the manufacturers.
Nazmul blamed vested quarters for making propaganda against the pharmaceutical sector, which will ultimately help India to push in their substandard medicines into the Bangladesh market.
"India is campaigning for deleting Bangladesh from WTO enlistment, under which Bangladesh enjoys facility to export pharmaceutical items in different countries," he said.
Former state minister for Health Mizanur Rahman Sinha, Kaiser Kabir, Dr Momenul Huq, MA Hasan, M Faruk and Naser Shahriar Jabedi were present at the discussion.
"We the four companies will be able to export and fetch US$ 10-15 million each by exporting our products," said Abdul Muktadir, managing director of Incepta Pharmaceuticals Limited Sunday.
He was speaking at a discussion session on 'Pharmaceutical Sector' at the Jatiya Press Club in the city. Bangladesh Aushad Shilpa Samity (BASS) organised the discussion with its president Shafiuzzaman in the chair.
Muktadir did not give further details about the export potentials of pharmaceutical products.
But sources said Incepta, Square, Beximco and Renata pharmaceuticals are ready to export their products. On the other hand, Popular and Healthcare Pharmaceuticals are preparing to export their products in European markets within a short time.
BASS general secretary Nazmul Hassan presented a power-point presentation on "Pharmaceutical Industry in Bangladesh: Some facts and figures".
BASS appealed to the government to re-fix the price of essential drugs for the domestic market, which was fixed in 1982.
In 1982, the government included 150 drugs in the essential list while in 1994, 117 items were identified as common used drugs.
"It is very much irrational to continue with the price that was fixed in 1982," Nazmul said.
He said currently they sell most of the commonly used medicines in the country below the production cost. "It is not possible to continue the production of these essential drugs without raising the price," he said.
Nazmul refuted the report in a section of the press that the manufacturers had increased the price of some essential drugs. "We have no involvement in the price hike," he asserted.
He said there are two types of pricing drugs in Bangladesh - controlled and decontrolled categories. Price of decontrolled drugs is proposed by the manufacturers.
Nazmul blamed vested quarters for making propaganda against the pharmaceutical sector, which will ultimately help India to push in their substandard medicines into the Bangladesh market.
"India is campaigning for deleting Bangladesh from WTO enlistment, under which Bangladesh enjoys facility to export pharmaceutical items in different countries," he said.
Former state minister for Health Mizanur Rahman Sinha, Kaiser Kabir, Dr Momenul Huq, MA Hasan, M Faruk and Naser Shahriar Jabedi were present at the discussion.